IP Library › Patent Application 16396056
Patent Application
App. No. 16/396,056

PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/396,056
Abstract

The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Claims (41)

1 - 35 . (canceled)

36 . A compound selected from the following group:

or a salt or stereoisomer thereof.

37 . The compound according to claim 36 , wherein the compound is:

or a salt or stereoisomer thereof.

38 . The compound according to claim 36 , wherein the compound is:

or a salt or stereoisomer thereof.

39 . The compound according to claim 36 , wherein the compound is:

or a salt or stereoisomer thereof.

40 . A compound selected from the following group:

or a salt or stereoisomer thereof.

41 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

42 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

43 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

44 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

45 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

46 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

47 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

48 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

49 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

50 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

51 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

52 . The compound according to claim 40 , wherein the compound is:

or a salt or stereoisomer thereof.

53 . A compound selected from the following group:

or a salt or stereoisomer thereof.

54 . The compound according to claim 53 , wherein the compound is:

or a salt or stereoisomer thereof.

55 . The compound according to claim 53 , wherein the compound is:

or a salt or stereoisomer thereof.

Assignments (1)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →